Skip to Main Content (Press Enter)

Logo UNISS
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze

Logo UNISS

|

UNIFIND

uniss.it
  • ×
  • Home
  • Corsi
  • Insegnamenti
  • Professioni
  • Persone
  • Pubblicazioni
  • Strutture
  • Terza Missione
  • Competenze
  1. Pubblicazioni

Tigecycline-Containing Regimens and Multi Drug-Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis

Articolo
Data di Pubblicazione:
2023
Citazione:
Tigecycline-Containing Regimens and Multi Drug-Resistant Acinetobacter baumannii: A Systematic Review and Meta-Analysis / Sodeifian, Fatemeh; Zangiabadian, Moein; Arabpour, Erfan; Kian, Naghmeh; Yazarlou, Fartous; Goudarzi, Mehdi; Centis, Rosella; Seghatoleslami, Zahra Sadat; Kameh, Mahdis Chahar; Danaei, Bardia; Goudarzi, Hossein; Nasiri, Mohammad Javad; Sotgiu, Giovanni; Migliori, Giovanni Battista. - In: MICROBIAL DRUG RESISTANCE. - ISSN 1076-6294. - 29:8(2023), pp. 344-359. [10.1089/mdr.2022.0248]
Abstract:
Introduction: The use of tigecycline (TG) for the treatment of Acinetobacter baumannii is controversial. In this systematic review and meta-analysis, we aimed to better explore the safety and efficacy of TG for the treatment of multi drug-resistant (MDR) Acinetobacter. Methods: We searched PubMed/MEDLINE, Scopus, Cochrane Central, and Web of Science to identify studies reporting the clinical and microbiological efficacy and safety of regimens containing TG in patients with drug susceptibility testing (DST)-confirmed MDR A. baumannii, published until December 30, 2022. Observational studies were included if they reported clinical and microbiological efficacy of TG-based regimens. The Newcastle-Ottawa Scale (NOS) and Joana Briggs Institute (JBI) critical appraisal tool were used to assess the quality of included studies. Results: There were 30 observational studies, of which 19 studies were cohort and 11 studies were single group studies. Pooled clinical response and failure rates in the TG-containing regimens group were 58.1 (95% confidence interval [CI] 49.2-66.6) and 40.2 (95% CI 31.1-50.0), respectively. The pooled microbiological response rate was 32.1 (95% CI 19.8-47.5), and the pooled all-cause mortality rate was 41.1 (95% CI 34.1-48.4). Pooled clinical response and failure rates in the colistin-based regimens group were 52.7 (42.7-62.5) and 43.1 (33.1-53.8), respectively. The pooled microbiological response rate was 42.9 (16.2-74.5), and the pooled all-cause mortality rate was 34.3 (26.1-43.5). Conclusions: According to our results, the efficacy of the TG-based regimen is the same as other antibiotics. However, our study showed a high mortality rate and a lower rate of microbiological eradication for TG compared with colistin-based regimen. Therefore, our study does not recommend it for the treatment of MDR A. baumannii. However, this was a prevalence meta-analysis of observational studies, and for better conclusion experimental studies are required.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
efficacy; meta-analysis; multi drug-resistant A. baumannii; safety; systematic review; tigecycline
Elenco autori:
Sodeifian, Fatemeh; Zangiabadian, Moein; Arabpour, Erfan; Kian, Naghmeh; Yazarlou, Fartous; Goudarzi, Mehdi; Centis, Rosella; Seghatoleslami, Zahra Sadat; Kameh, Mahdis Chahar; Danaei, Bardia; Goudarzi, Hossein; Nasiri, Mohammad Javad; Sotgiu, Giovanni; Migliori, Giovanni Battista
Autori di Ateneo:
SOTGIU Giovanni
Link alla scheda completa:
https://iris.uniss.it/handle/11388/368552
Pubblicato in:
MICROBIAL DRUG RESISTANCE
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.1.0